Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-068749
Filing Date
2007-03-29
Accepted
2007-03-29 16:22:30
Documents
11
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1088044
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE REGISTRANT dex31.htm EX-3.1 41254
3 AMENDED AND RESTATED BYLAWS dex32.htm EX-3.2 92312
4 AMENDMENT NO. 1 TO RESEARCH COLLABORATION AND LICENCE AGREEMENT dex102.htm EX-10.2 10458
5 EMPLOYMENT AGREEMENT BETWEEN THE REGISTRANT AND MARY KAY FENTON dex1010.htm EX-10.10 34103
6 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1436
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 5533
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 5519
9 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 dex321.htm EX-32.1 3131
10 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 dex322.htm EX-32.2 3104
11 GRAPHIC g94580g36w92.jpg GRAPHIC 66238
  Complete submission text file 0001193125-07-068749.txt   1377636
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33095 | Film No.: 07727901
SIC: 2834 Pharmaceutical Preparations